 The purpose of this study is to assess the pharmacokinetics the study of the way a drug enters and leaves the blood and tissues over time and pharmacodynamics the way a drug may change body function of a single 15-milligram mg dose of rivaroxaban in both healthy participants with a creatinine clearance CLcr greater than equal to 80 milliliter per minute mLmin and clinically stable participants with end-stage renal disease ESRD on maintenance hemodialysis a method used to remove waste material from the blood when the kidneys are unable to do so. 